ClinicalSeriesLive

Continuing Education Speakers

 

  • Mark T. Dunbar, OD, FAAO

    Mark T. Dunbar, OD, FAAO

    Mark T. Dunbar, OD, FAAO

    Mark T. Dunbar, OD, FAAO, has been a member of the optometric staff at the University of Miami’s Bascom Palmer Eye Institute in Miami, Florida, for almost 30 years, where he is currently director of optometric services and the optometric residency supervisor. He is a fellow of the American Academy of Optometry, as well as a founding member of both the Optometric Glaucoma Society (OGS) and the Optometric Retina Society (ORS). Dr Dunbar also serves on the editorial boards for Advanced Ocular Care and Review of Optometry, where he writes the monthly column, “The Retina Quiz.” He graduated from the Michigan College of Optometry at Ferris State University in Big Rapids, Michigan, and completed an ocular disease fellowship at the Omni Eye Services of Lexington, Kentucky.
  • Dean Eliott, MD

    Dean Eliott, MD

    Dean Eliott, MD

    Associate Director, Retina Service

    Dean Eliott, MD, is the Stelios Evangelos Gragoudas Associate Professor of Ophthalmology, associate director, Retina Service, and the retina fellowship director at the Massachusetts Eye and Ear Infirmary of Harvard Medical School in Boston. Dr Eliott specializes in diabetic retinopathy, retinal detachment, trauma, and surgery for complex retina-vitreous disorders. He has been a principal investigator for many clinical trials, is on the editorial board for several journals, and has over 200 publications in ophthalmic journals and textbooks. Dr Eliott earned his medical degree from Vanderbilt University School of Medicine, completed his residency at the Wilmer Eye Institute of Johns Hopkins Hospital, and completed a retina fellowship at the Duke Eye Center of Duke University Medical Center.
  • Jonathan Kay, MD

    Jonathan Kay, MD

    Jonathan Kay, MD

    Professor of Medicine

    Jonathan Kay, MD, received his medical degree from the University of California School of Medicine in San Francisco, California. He then completed an internship and residency at the Hospital of the University of Pennsylvania in Philadelphia and fellowships in rheumatology and immunology at The Brigham and Women’s Hospital and Harvard Medical School in Boston, Massachusetts. Dr. Kay is Professor of Medicine at the University of Massachusetts Medical School and a Physician at UMass Memorial Medical Center in Worcester, where he directs Clinical Research in the Division of Rheumatology. Dr. Kay lectures internationally and is the author of more than 120 publications and book chapters.
  • Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP

    Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP

    Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP

    Clinical Pharmacist

    Alissa R. Segal, PharmD, RPh, CDE, CDTC, FCCP is an Associate Professor at MCPHS University and clinical pharmacist at the Joslin Diabetes Center, Boston, MA. After completing post-doctorate residencies at the Medical Center at Princeton and the Medical University of South Carolina, Dr. Segal taught for several years at the University of New Mexico. In 2007, she joined MCPHS University and established clinical pharmacy services at the Joslin. Her research focus on the care of adults with diabetes has led to numerous publications, on diabetes in older adults and concentrated insulin, and book chapters in the Joslin Deskbook, Endocrine and Metabolic Medical Emergencies, and Geriatric Diabetes. She was one of the first pharmacists to receive the Certified Diabetes Technology Clinician certification and is a fellow of the American College of Clinical Pharmacy (ACCP).
  • Andrew Evens, DO, MSc

    Andrew Evens, DO, MSc

    Andrew Evens, DO, MSc

    Professor of Medicine

    Dr. Evens is Professor of Medicine at Tufts University School of Medicine and he is Chief of the Division of Hematology/Oncology and Director of the Tufts Cancer Center at Tufts Medical Center in Boston, Massachusetts. He was also named the Chan Soon-Shiong Endowed Scholar in Precision Medicine at Tufts Medical Center. Dr. Evens completed his Hematology/Oncology fellowship at Northwestern University Feinberg School of Medicine and The Robert H. Lurie Comprehensive Cancer Center (RHLCCC). As a physician-scientist, Dr. Evens’ focus is in the biology, prognosis, and treatment of Non-Hodgkin lymphoma and Hodgkin disease/lymphoma. He has designed and conducted a multitude of clinical trials in lymphoid malignancies and he has authored or co-authored more than 150 original articles in this field.